Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ sigma-tau i.f.r. S.p.A.
sigma-tau i.f.r. S.p.A.
Industry · 14 registered clinical trials.
Status
Trial
Phase
Started
Terminated
131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
Breast Neoplasm, Head and Neck Neoplasm, Skin Neoplasm
Phase 1
2015-11-01
Completed
A Pharmacokinetic/Pharmacodynamic Study of Eurartesim Dispersible Formulation in Infants With P.Falciparum Mal
Malaria,Falciparum
Phase 2
2013-11-01
Terminated
Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Colitis; Efficacy, Safety and Tolerabilit
Ulcerative Colitis
Phase 3
2012-04-01
Terminated
Efficacy, Safety and Tolerability of Propionyl-L-Carnitine Hydrochloride in Patients With Mild Ulcerative Coli
Ulcerative Colitis
Phase 3
2012-04-01
Completed
Food Interaction Study on the Pharmacokinetics of Eurartesim™ (DHA and PQP)in Healthy Male Adult Volunteers
Malaria, Falciparum
Phase 1
2010-03-01
Completed
A Pharmacokinetic (PK) Trial in Healthy Asian and Caucasian Volunteers Investigating the PK Profile of Eurarte
Malaria, Falciparum
Phase 1
2010-02-01
Completed
Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy Volunteers
Malaria, Falciparum
Phase 1
2010-02-01
Completed
A Pilot Study to Evaluate ZADAXIN's® (Thymalfasin) Ability to Enhance Immune Response to the H1N1sw Influenza
END STAGE RENAL DISEASE
Phase 2
2009-11-01
Completed
ST1968 Intravenous (Weekly) in Solid Tumors
Solid Tumors
Phase 1
2007-06-01
Completed
A Phase II Trial to Assess Hemodynamic Effects of Istaroxime in Pts With Worsening HF and Reduced LV Systolic
Heart Failure
Phase 2
2006-08-01
Completed
Propionyl-L-Carnitine in Ulcerative Colitis
Ulcerative Colitis
Phase 2
2006-05-01
Completed
Efficacy of Rostafuroxin in the Treatment of Essential Hypertension
Essential Hypertension
Phase 2
2005-02-01
Completed
Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatiti
Chronic Hepatitis C
Phase 3
2004-12-01
Completed
Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melano
Malignant Melanoma
Phase 2
2002-07-01